1. Home
  2. CRDF vs IBEX Comparison

CRDF vs IBEX Comparison

Compare CRDF & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • IBEX
  • Stock Information
  • Founded
  • CRDF 1999
  • IBEX 2017
  • Country
  • CRDF United States
  • IBEX United States
  • Employees
  • CRDF N/A
  • IBEX N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • IBEX EDP Services
  • Sector
  • CRDF Health Care
  • IBEX Technology
  • Exchange
  • CRDF Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • CRDF 210.2M
  • IBEX 337.3M
  • IPO Year
  • CRDF N/A
  • IBEX 2020
  • Fundamental
  • Price
  • CRDF $3.65
  • IBEX $30.46
  • Analyst Decision
  • CRDF Strong Buy
  • IBEX Hold
  • Analyst Count
  • CRDF 5
  • IBEX 2
  • Target Price
  • CRDF $10.50
  • IBEX $27.00
  • AVG Volume (30 Days)
  • CRDF 1.4M
  • IBEX 155.0K
  • Earning Date
  • CRDF 08-07-2025
  • IBEX 05-08-2025
  • Dividend Yield
  • CRDF N/A
  • IBEX N/A
  • EPS Growth
  • CRDF N/A
  • IBEX 48.53
  • EPS
  • CRDF N/A
  • IBEX 2.25
  • Revenue
  • CRDF $587,000.00
  • IBEX $535,666,000.00
  • Revenue This Year
  • CRDF N/A
  • IBEX $9.12
  • Revenue Next Year
  • CRDF N/A
  • IBEX $5.80
  • P/E Ratio
  • CRDF N/A
  • IBEX $13.59
  • Revenue Growth
  • CRDF N/A
  • IBEX 5.35
  • 52 Week Low
  • CRDF $2.01
  • IBEX $15.15
  • 52 Week High
  • CRDF $5.64
  • IBEX $32.08
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 58.47
  • IBEX 63.39
  • Support Level
  • CRDF $3.07
  • IBEX $27.37
  • Resistance Level
  • CRDF $3.24
  • IBEX $29.66
  • Average True Range (ATR)
  • CRDF 0.23
  • IBEX 0.88
  • MACD
  • CRDF 0.01
  • IBEX 0.15
  • Stochastic Oscillator
  • CRDF 66.99
  • IBEX 87.29

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: